Compound class:
Synthetic organic
Comment: KC-180-2 is a dual action tubulin polymerisation inhibitor and Src kinase inhibitor that was developed as a refined derivative of the anti-cancer agent tirbanibulin (KX2-391) [1]. Destabilisation of tubulin polymers is the primary mechanism that underlies KC-180-2's effects on cell cycle arrest in cancer cells. KC-180-2 occupies the same non-ATP substrate binding pocket within Src as KX2-391.
|
|
References |
1. Peng J, Zeng Y, Hu X, Huang S, Gao X, Tian D, Tian S, Qiu L, Dong R, Zhan W et al.. (2022)
KC-180-2 Exerts Anti-SCLC Effects via Dual Inhibition of Tubulin Polymerization and Src Signaling. ACS Omega, Epub ahead of print. DOI: 10.1021/acsomega.2c03408 |